Wellbutrin (bupropion) is not FDA-approved for any anxiety disorder. It is approved for major depression, seasonal affective disorder, and smoking cessation. That said, some doctors do prescribe it off-label for anxiety, and a small but growing body of evidence suggests it may help certain types of anxiety, particularly when anxiety overlaps with depression or when first-line options cause intolerable side effects.
Why Wellbutrin Works Differently Than Typical Anxiety Medications
Most medications prescribed for anxiety disorders, like SSRIs and SNRIs, work primarily by increasing serotonin levels in the brain. Wellbutrin doesn’t touch serotonin at all. Instead, it blocks the reabsorption of two other brain chemicals: dopamine and norepinephrine. This makes more of both available in key areas of the brain involved in motivation, focus, and mood regulation. It’s the only antidepressant on the market with this specific combination of effects.
This unique profile is a double-edged sword when it comes to anxiety. On one hand, boosting dopamine can help people who feel flat, unmotivated, or mentally foggy alongside their anxiety. On the other hand, increasing norepinephrine is an activating effect. It raises alertness and energy, which is great for depression but can temporarily worsen anxiety symptoms in some people, especially during the first few weeks of treatment.
What the Evidence Says About Generalized Anxiety
The strongest signal for Wellbutrin’s anxiety-reducing potential comes from a controlled trial comparing it head-to-head with escitalopram (Lexapro), one of the most commonly prescribed medications for generalized anxiety disorder (GAD). In that 12-week, double-blind study of 24 outpatients with GAD, Wellbutrin XL demonstrated comparable anxiety-reducing effects to escitalopram, and both medications were well tolerated. That’s a notable finding, even though the study was small and described by its authors as a pilot project warranting further research.
Separately, studies comparing Wellbutrin to SSRIs like sertraline (Zoloft) and fluoxetine (Prozac) in patients with depression have found that Wellbutrin produced positive results in treating the anxiety symptoms that accompanied the depression. This matters because depression and anxiety co-occur in a large number of patients, and a medication that addresses both without the sexual side effects common to SSRIs is valuable.
Wellbutrin and Panic Disorder
The picture is murkier for panic disorder. Clinical lore has long suggested that Wellbutrin might not be a good fit for people who experience panic attacks, partly because its stimulating properties could theoretically trigger them. One early controlled study reinforced that skepticism. However, an eight-week open-label trial of 20 outpatients with panic disorder found statistically significant improvement across every measure the researchers tracked: overall severity, number of panic attacks over two-week periods, and time spent in anticipatory anxiety. Patients improved by one to two points on a standard clinical severity scale.
The catch is that the trial was open-label, meaning both patients and doctors knew what medication was being taken, which can inflate results through placebo effects. The researchers acknowledged this limitation and called for controlled follow-up studies. So while the results are encouraging, they’re far from definitive. If panic attacks are your primary concern, SSRIs and SNRIs remain better-supported options.
When Doctors Typically Prescribe It for Anxiety
In practice, Wellbutrin tends to be prescribed for anxiety in a few specific scenarios rather than as a go-to first choice.
- Anxiety with depression: When both conditions are present, Wellbutrin can address the depressive symptoms (low energy, poor concentration, lack of motivation) while providing some anxiety relief. Clinical guidelines for major depression list bupropion as a first-line antidepressant, and note that all first-line antidepressants are recommended when depression presents with anxious distress.
- SSRI side effects are a problem: Up to 46% of patients don’t respond adequately to their initial antidepressant. For people who experience sexual dysfunction, weight gain, or emotional blunting on SSRIs, Wellbutrin offers a fundamentally different side effect profile. It’s weight-neutral and rarely causes sexual side effects.
- As an add-on to an SSRI: Survey data from over 800 clinicians in the United States and Canada found that bupropion was the most commonly chosen medication to add when an SSRI alone wasn’t working well enough. The combination can address residual symptoms, including anxiety, and counteract SSRI-related sexual side effects.
Side Effects That Matter for Anxious People
If you already deal with anxiety, you’ll want to know that the most common side effects of Wellbutrin overlap with anxiety symptoms: insomnia, restlessness, increased heart rate, and dry mouth. For many people, these effects are most noticeable in the first one to two weeks and then settle down. But for others, especially those with high baseline anxiety or a history of panic attacks, the initial activation can feel genuinely uncomfortable.
Starting at a lower dose and increasing gradually is the standard approach to minimize this. Wellbutrin comes in immediate-release, sustained-release (SR), and extended-release (XL) formulations. The XL version releases medication more slowly throughout the day, which generally produces a smoother experience with fewer spikes in side effects. Most of the anxiety-related research has used the SR or XL formulations.
One serious but rare risk is seizures, which occur at higher rates when doses exceed the recommended ceiling or in people with certain risk factors like eating disorders or heavy alcohol use. This isn’t specific to anxiety patients, but it’s worth knowing.
How It Compares to Standard Anxiety Treatments
SSRIs and SNRIs remain the first-line medications for most anxiety disorders, including GAD, social anxiety disorder, and panic disorder. They have decades of large-scale clinical trial data behind them for these specific conditions. Wellbutrin simply doesn’t have that depth of evidence for anxiety as a standalone diagnosis.
Benzodiazepines work faster for acute anxiety but carry risks of dependence and are generally recommended only for short-term use. Buspirone is another non-addictive option specifically approved for anxiety, though it can take several weeks to reach full effect. Wellbutrin occupies a different niche: it’s most useful when anxiety coexists with depression, low energy, or concentration problems, or when the side effect profile of other options is a dealbreaker.
The practical takeaway is that Wellbutrin can help with anxiety for certain people in certain situations, but it’s not typically the first medication a clinician reaches for when anxiety is the primary and only diagnosis. Its real strength lies in treating the overlap between anxiety and depression while avoiding the side effects that make other antidepressants difficult to tolerate long-term.